nderstanding circulatory control in postural orthostatic tachycardia syndrome

niversity of Auckland0 个研究点目标入组 50 人开始时间: 2024年4月3日最近更新: 2024年4月8日

适应症

试验速览

暂无简介。

•Severe cardiac disease (e.g., coronary artery disease, heart failure, hypertension)
•Primary / secondary autonomic dysfunction
•Significant arrhythmias (e.g., atrial fibrillation, previous VT / significant ventricular ectopy)
•Severe respiratory disease (e.g., chronic obstructive pulmonary disease)
•Severe, uncontrolled type II diabetes
•Significant renal or liver disease
•Significant neurological disease including diabetic neuropathy
•Current active treatment for cancer
•Inflammatory disease
•Infection or pyrexial illness
•Uncontrolled thyroid disorders
•Recent (< 3 months) ischemic stroke
•Current smoker/vaper
•Current pregnancy
•Users of recreational drugs
•Current hazardous alcohol use. Participant’s alcohol intake will be initially screened in the Health Screening Questionnaire. If alcohol intake exceeds recommended limits, then the participant will be assessed by AUDIT questionnaire for hazardous alcohol intake (score of 8 or more on AUDIT).
•Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
•Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study

发起方

niversity of Auckland